American CryoStem Corporation
CRYO · OTC
6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Revenue | $43 | $32 | $61 | -$363 |
| % Growth | 33.4% | -47.8% | 116.9% | – |
| Cost of Goods Sold | $5 | $3 | $19 | $5 |
| Gross Profit | $38 | $29 | $42 | -$368 |
| % Margin | 88.8% | 90.6% | 69.2% | 101.4% |
| R&D Expenses | $36 | $210 | $22 | $98 |
| G&A Expenses | $296 | $757 | $375 | $974 |
| SG&A Expenses | $313 | $757 | $375 | $975 |
| Sales & Mktg Exp. | $17 | $0 | $0 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | -$0 |
| Operating Expenses | $349 | $967 | $397 | $1,073 |
| Operating Income | -$377 | -$938 | -$354 | -$1,982 |
| % Margin | -884.6% | -2,938.6% | -579.4% | 546.5% |
| Other Income/Exp. Net | -$25 | -$25 | -$26 | -$80 |
| Pre-Tax Income | -$402 | -$964 | -$381 | -$2,062 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$402 | -$964 | -$381 | -$2,062 |
| % Margin | -943% | -3,018% | -622.3% | 568.5% |
| EPS | -0.009 | -0.022 | -0.007 | -0.034 |
| % Growth | 59.1% | -214.3% | 79.5% | – |
| EPS Diluted | -0.009 | -0.022 | -0.007 | -0.034 |
| Weighted Avg Shares Out | 43,995 | 43,548 | 53,542 | 60,496 |
| Weighted Avg Shares Out Dil | 43,995 | 43,548 | 53,542 | 60,496 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $25 | $25 | $26 | $25 |
| Depreciation & Amortization | $21 | $28 | $15 | $12 |
| EBITDA | -$356 | -$911 | -$340 | -$2,025 |
| % Margin | -834.7% | -2,852.2% | -555.6% | 558.4% |